PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,552,000 | +31.2% | 40,000 | +100.0% | 0.57% | +25.7% |
| Q2 2018 | $1,183,000 | -30.5% | 20,000 | -20.0% | 0.46% | -42.7% |
| Q1 2018 | $1,701,000 | -50.8% | 25,000 | -28.6% | 0.79% | -38.2% |
| Q4 2017 | $3,460,000 | +44.5% | 35,000 | +75.0% | 1.28% | +57.5% |
| Q3 2017 | $2,395,000 | +37.0% | 20,000 | 0.0% | 0.82% | +27.3% |
| Q2 2017 | $1,748,000 | +56.6% | 20,000 | -33.3% | 0.64% | +23.1% |
| Q1 2017 | $1,116,000 | +21.2% | 30,000 | 0.0% | 0.52% | +18.5% |
| Q4 2016 | $921,000 | – | 30,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |